Revenue: The sum of all revenue fields included for a company's operating activities.
Black Diamond Therapeutics, Inc. (BDTX) had Revenue of $70.00M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$70.00M |
$56.54M |
|
-- |
|
$70.00M |
|
$15.47M |
|
$54.53M |
|
$2.01M |
|
$56.54M |
|
$56.54M |
|
$56.54M |
|
$56.54M |
|
$56.54M |
|
$56.54M |
|
$54.53M |
|
$54.62M |
|
56.66M |
|
57.67M |
|
$1.00 |
|
$0.98 |
|
| Balance Sheet Financials | |
$155.68M |
|
$1.30M |
|
$20.57M |
|
$176.25M |
|
$16.85M |
|
-- |
|
$17.88M |
|
$34.73M |
|
$141.52M |
|
$141.52M |
|
$141.52M |
|
56.68M |
|
| Cash Flow Statement Financials | |
$53.41M |
|
$8.55M |
|
$0.03M |
|
$37.26M |
|
$99.25M |
|
$61.99M |
|
$1.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
77.90% |
|
77.90% |
|
-- |
|
80.77% |
|
80.77% |
|
$53.42M |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
-- |
|
-- |
|
-- |
|
39.95% |
|
39.95% |
|
32.08% |
|
39.95% |
|
$2.50 |
|
$0.93 |
|
$0.93 |
|